Achilleas Gravanis

Achilleas Gravanis, Professor of Pharmacology Medical School University of Crete and Researcher at the Institute of Molecular Biology & Biotechnology-FORTH.  He served as member of the Biomedical Research Program Committee of the European Commission, as member of the Hellenic Council of the Higher Education Quality Assurance Authority (ADIP) and President of the Sectional Committee of Life Sciences Hellenic National Research & Technology Council (ESET), also member of the Council of the Hellenic Research & Innovation Foundation (ELIDEK), responsible for Life Sciences. Affiliated Research Professor Center for Drug Discovery, Northeastern University Boston. Co-founder of biotechnology spinoffs BioNature and ReNeuroCell. Affiliated Principal Investigator Emulate spin-off WYSS/Harvard. Member of the Board of Directors, Athens LifeTech Park. Venture partner at BigPi Ventures. His research group is developing synthetic compounds, agonists of neurotrophin receptors, with neuroprotective and neurogenic properties and potential applications in therapeutics of neurodegenerative diseases. Additionally, his group is focusing on 3D microscaffold bioengineering and neural stem cell technologies to develop neuroimplants for spinal cord injury and brain trauma and neurobiosensors for drug discovery.